Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired stock | Association of Anaesthetists

Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired stock

Zantac – MHRA drug alert issued as GlaxoSmithKline recalls all unexpired stock

The MHRA has issued an alert widely recalling most brands of ranitidine as a precaution due to contamination during manufacture. Advice is to stop supplying the products immediately, quarantine all remaining stock and return it to their supplier. Anaesthetists may need to consider alternatives and adapt protocols until the problem resolves.

Find out more

You may also be interested in: